Literature DB >> 22889982

Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.

Sergio Morini1, Giuseppe Perrone, Domenico Borzomati, Bruno Vincenzi, Carla Rabitti, Daniela Righi, Federica Castri, Andrea D Manazza, Daniele Santini, Giuseppe Tonini, Roberto Coppola, Andrea Onetti Muda.   

Abstract

OBJECTIVES: The objective of the study was to verify if histopathological differentiation of ampullary carcinoma after surgical resection may be related to survival.
METHODS: The prognostic role of an accurate histological and immunohistochemical classification has been investigated in a multicentric series of carcinoma of the ampulla of Vater. Immunohistochemical expression of cytokeratin 7 (CK7) and CK20 were analyzed in the different morphological histotypes of ampullary cancers, and results were compared with overall survival.
RESULTS: Of 72 ampullary cancers, 48.6% were classified as pancreaticobiliary-type carcinomas, 43.1% were classified as intestinal-type carcinomas, and 8.3% were classified as "unusual"-type carcinomas. Cytokeratin 20 was expressed in 28 (90.3%) of the 31 intestinal-type carcinomas, whereas it was always negative in the pancreaticobiliary histotype; CK7 was expressed in 32 (91.4%) of the 35 pancreaticobiliary-type carcinomas and in 18 (58.1%) of the 31 intestinal-type carcinomas. By univariate analysis, overall survival was influenced significantly by pathological T factor, lymph node involvement, and histological/immunohistochemical subtyping. Furthermore, using a multivariate Cox regression model, lymph node metastasis and CK20 were identified as significant independent factors related to prognosis.
CONCLUSION: Our results prove the clinical use of ampullary cancer subclassification based on different histotypes and indicate the useful role of the CK7/CK20 expression profile for consistent histopathological classification and prognostic relevance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22889982     DOI: 10.1097/MPA.0b013e318258fda8

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  16 in total

1.  Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.

Authors:  João Paulo Lemos da Silveira Santos; Carla Jorge Machado; Eduardo Paulino Junior; João Bernardo Sancio Rocha Rodrigues; Paula Teixeira Vidigal; Vivian Resende
Journal:  J Gastrointest Surg       Date:  2018-05-07       Impact factor: 3.452

2.  Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.

Authors:  Winston Wong; Maeve A Lowery; Michael F Berger; Yelena Kemel; Barry Taylor; Ahmet Zehir; Preethi Srinivasan; Chaitanya Bandlamudi; Joanne Chou; Marinela Capanu; Anna Varghese; Kenneth H Yu; Christine A Iacobuzio-Donahue; Jinru Shia; David S Klimstra; William R Jarnagin; Zsofia K Stadler; Eileen M O'Reilly
Journal:  Cancer       Date:  2019-01-08       Impact factor: 6.860

3.  Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.

Authors:  Michelle D Reid; Serdar Balci; Nobuyuki Ohike; Yue Xue; Grace E Kim; Takuma Tajiri; Bahar Memis; Ipek Coban; Anil Dolgun; Alyssa M Krasinskas; Olca Basturk; David A Kooby; Juan M Sarmiento; Shishir K Maithel; Bassel F El-Rayes; Volkan Adsay
Journal:  Mod Pathol       Date:  2016-09-02       Impact factor: 7.842

4.  Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer.

Authors:  Tobias S Schiergens; Bernhard W Renz; Simone Reu; Jens Neumann; Rami Al-Sayegh; Hanno Nieß; Matthias Ilmer; Stephan Kruger; Stefan Boeck; Volker Heinemann; Jens Werner; Axel Kleespies
Journal:  J Gastrointest Surg       Date:  2017-09-05       Impact factor: 3.452

5.  Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma-A National Cohort Study.

Authors:  Ibrahim Nassour; Alana Christie; Michael A Choti; John C Mansour; Rebecca M Minter; Patricio M Polanco; Mathew M Augustine; Matthew R Porembka; Xian-Jin Xie; Sam C Wang
Journal:  J Gastrointest Surg       Date:  2018-03-15       Impact factor: 3.452

6.  Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma.

Authors:  Hye Jin Choi; Chang Moo Kang; Kwanhyeong Jo; Woo Jung Lee; Jae-Hoon Lee; Young Hoon Ryu; Jong Doo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-13       Impact factor: 9.236

7.  Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.

Authors:  Marie-Claude Gingras; Kyle R Covington; David K Chang; Lawrence A Donehower; Anthony J Gill; Michael M Ittmann; Chad J Creighton; Amber L Johns; Eve Shinbrot; Ninad Dewal; William E Fisher; Christian Pilarsky; Robert Grützmann; Michael J Overman; Nigel B Jamieson; George Van Buren; Jennifer Drummond; Kimberly Walker; Oliver A Hampton; Liu Xi; Donna M Muzny; Harsha Doddapaneni; Sandra L Lee; Michelle Bellair; Jianhong Hu; Yi Han; Huyen H Dinh; Mike Dahdouli; Jaswinder S Samra; Peter Bailey; Nicola Waddell; John V Pearson; Ivon Harliwong; Huamin Wang; Daniela Aust; Karin A Oien; Ralph H Hruban; Sally E Hodges; Amy McElhany; Charupong Saengboonmee; Fraser R Duthie; Sean M Grimmond; Andrew V Biankin; David A Wheeler; Richard A Gibbs
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

8.  Racial and ethnic disparities in a national cohort of ampullary cancer patients.

Authors:  Ibrahim Nassour; Ali A Mokdad; Rebecca M Minter; Patricio M Polanco; Mathew M Augustine; John C Mansour; Matthew R Porembka; Sam C Wang
Journal:  J Surg Oncol       Date:  2017-10-02       Impact factor: 3.454

9.  Ampullary and pancreatic adenocarcinoma-a comparative study.

Authors:  Marwa Ferchichi; Raja Jouini; Wafa Koubaa; Fatma Khanchel; Imen Helal; Dhafer Hadad; Norsaf Bibani; Aschraf Chadli-Debbiche; Ehsen BenBrahim
Journal:  J Gastrointest Oncol       Date:  2019-04

10.  KRAS, NRAS and BRAF analysis of ampullary adenocarcinoma classified using CK7, CK20, MUC1 and MUC2.

Authors:  Marwa Ferchichi; Raja Jouini; Imen Ayari; Wafa Koubaa; Aschraf Chadli-Debbiche; Ehsen BenBrahim
Journal:  J Gastrointest Oncol       Date:  2018-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.